Engineered MHC class I antigens as allogenizing molecules. Potential for tumor immunotherapy.
| Autor: | Kesari KV; Howard Hughes Medical Institute, Rockefeller University, New York, New York 10021., Geliebter J |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 1994 May 31; Vol. 716, pp. 324-6. |
| DOI: | 10.1111/j.1749-6632.1994.tb21723.x |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Plný text